A compassionate use trial of MIP-1095-I-131 in patients with heavily-pretreated advanced prostate cancer
Latest Information Update: 27 Feb 2017
Price :
$35 *
At a glance
- Drugs LNTH 1095 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 27 Feb 2017 New trial record